EP Patent

EP0518731B1 — Dérivés de 2-(indol-2-yl-carbonylamino)-thiazoles,leur préparation et compositions pharmaceutiques en contenant

Assigned to Sanofi SA · Expires 1998-08-26 · 28y expired

What this patent protects

Patent listed against avatrombopag-maleate.

Drugs covered by this patent

avatrombopag-maleate (AVATROMBOPAG MALEATE)

Patent Metadata

Patent number: EP0518731B1
Jurisdiction: EP
Classification: —
Expires: 1998-08-26
Drug substance claim: No
Drug product claim: No
Assignee: Sanofi SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.